Cargando…
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment. In addition to its immune checkpoint function, B7-H3 has been linked to tumor...
Autores principales: | Getu, Ayechew Adera, Tigabu, Abiye, Zhou, Ming, Lu, Jianrong, Fodstad, Øystein, Tan, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979440/ https://www.ncbi.nlm.nih.gov/pubmed/36859240 http://dx.doi.org/10.1186/s12943-023-01751-9 |
Ejemplares similares
-
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development
por: Picarda, Elodie, et al.
Publicado: (2022) -
Orthostatic Hypotension in Male Hypertensive Patients: A Cross-Sectional Study at the University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia
por: Getu, Ayechew Adera, et al.
Publicado: (2021) -
Prevalence of Erectile Dysfunction and Associated Factors among Hypertensive Patients Attending Governmental Health Institutions in Gondar City, Northwest Ethiopia: A Cross-Sectional Study
por: Abuhay, Deribew Abebaw, et al.
Publicado: (2021) -
B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021) -
Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
por: Aicher, Wilhelm K., et al.
Publicado: (2021)